Report Description Request For TOC Research Methodology Download Free Sample

Market Snapshot

CAGR:6.94

2023

2032

Source: Market Expertz

Study Period	2019-2032
Base Year	2023
Forcast Year	2023-2032
CAGR	6.94

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Report Overview

In 2018, the global Antibody Drugs market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2019-2026.

This report focuses on the global Antibody Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antibody Drugs development in United States, Europe and China.

The key players covered in this study
Novartis
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
...

Market segment by Type, the product can be split into
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies

Market segment by Application, split into
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antibody Drugs status, future forecast, growth opportunity, key market and key players.
To present the Antibody Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antibody Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Antibody Drugs Market Size Growth Rate by Type (2014-2026)
1.4.2 Monoclonal Antibodies
1.4.3 Antibody-Drug Conjugates
1.4.4 Polyclonal Antibodies
1.5 Market by Application
1.5.1 Global Antibody Drugs Market Share by Application (2014-2026)
1.5.2 Central Nervous System (CNS) Disorders
1.5.3 Cancers
1.5.4 Autoimmune Disorders
1.5.5 Cardiovascular Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Antibody Drugs Market Size
2.2 Antibody Drugs Growth Trends by Regions
2.2.1 Antibody Drugs Market Size by Regions (2014-2026)
2.2.2 Antibody Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Antibody Drugs Market Size by Manufacturers
3.1.1 Global Antibody Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antibody Drugs Key Players Head office and Area Served
3.3 Key Players Antibody Drugs Product/Solution/Service
3.4 Date of Enter into Antibody Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Antibody Drugs Market Size by Type (2014-2019)
4.2 Global Antibody Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Antibody Drugs Market Size (2014-2019)
5.2 Antibody Drugs Key Players in United States
5.3 United States Antibody Drugs Market Size by Type
5.4 United States Antibody Drugs Market Size by Application

6 Europe
6.1 Europe Antibody Drugs Market Size (2014-2019)
6.2 Antibody Drugs Key Players in Europe
6.3 Europe Antibody Drugs Market Size by Type
6.4 Europe Antibody Drugs Market Size by Application

7 China
7.1 China Antibody Drugs Market Size (2014-2019)
7.2 Antibody Drugs Key Players in China
7.3 China Antibody Drugs Market Size by Type
7.4 China Antibody Drugs Market Size by Application

8 Japan
8.1 Japan Antibody Drugs Market Size (2014-2019)
8.2 Antibody Drugs Key Players in Japan
8.3 Japan Antibody Drugs Market Size by Type
8.4 Japan Antibody Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Antibody Drugs Market Size (2014-2019)
9.2 Antibody Drugs Key Players in Southeast Asia
9.3 Southeast Asia Antibody Drugs Market Size by Type
9.4 Southeast Asia Antibody Drugs Market Size by Application

10 India
10.1 India Antibody Drugs Market Size (2014-2019)
10.2 Antibody Drugs Key Players in India
10.3 India Antibody Drugs Market Size by Type
10.4 India Antibody Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Antibody Drugs Market Size (2014-2019)
11.2 Antibody Drugs Key Players in Central & South America
11.3 Central & South America Antibody Drugs Market Size by Type
11.4 Central & South America Antibody Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Antibody Drugs Introduction
12.1.4 Novartis Revenue in Antibody Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Antibody Drugs Introduction
12.2.4 Amgen Revenue in Antibody Drugs Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Antibody Drugs Introduction
12.3.4 Bristol-Myers Squibb Revenue in Antibody Drugs Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Antibody Drugs Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Antibody Drugs Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Antibody Drugs Introduction
12.5.4 Johnson & Johnson Revenue in Antibody Drugs Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Antibody Drugs Introduction
12.6.4 AbbVie Revenue in Antibody Drugs Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Antibody Drugs Introduction
12.7.4 Eli Lilly Revenue in Antibody Drugs Business (2014-2019)
12.7.5 Eli Lilly Recent Development

13 Market Forecast 2019-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2026)
13.10 Market Size Forecast by Application (2019-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Antibody Drugs Key Market Segments
Table Key Players Antibody Drugs Covered
Table Global Antibody Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Antibody Drugs Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Antibody-Drug Conjugates Figures
Table Key Players of Antibody-Drug Conjugates
Figure Polyclonal Antibodies Figures
Table Key Players of Polyclonal Antibodies
Table Global Antibody Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Central Nervous System (CNS) Disorders Case Studies
Figure Cancers Case Studies
Figure Autoimmune Disorders Case Studies
Figure Cardiovascular Diseases Case Studies
Figure Antibody Drugs Report Years Considered
Table Global Antibody Drugs Market Size 2014-2025 (Million US$)
Figure Global Antibody Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Antibody Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Antibody Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Antibody Drugs Market Share by Regions 2014-2019
Figure Global Antibody Drugs Market Share by Regions 2014-2019
Figure Global Antibody Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Antibody Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Antibody Drugs Market Share by Manufacturers (2014-2019)
Figure Global Antibody Drugs Market Share by Manufacturers in 2018
Table Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Antibody Drugs Product/Solution/Service
Table Date of Enter into Antibody Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Antibody Drugs Market Size Share by Type (2014-2019)
Figure Global Antibody Drugs Market Size Market Share by Type (2014-2019)
Table Global Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Antibody Drugs Market Size Share by Application (2014-2019)
Figure Global Antibody Drugs Market Size Market Share by Application (2014-2019)
Figure Global Antibody Drugs Revenue Market Share by Application in 2018
Figure United States Antibody Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Antibody Drugs Market Share (2018-2019)
Table United States Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Antibody Drugs Market Share by Type (2014-2019)
Table United States Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Antibody Drugs Market Share by Application (2014-2019)
Figure Europe Antibody Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Antibody Drugs Market Share (2018-2019)
Table Europe Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Antibody Drugs Market Share by Type (2014-2019)
Table Europe Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Antibody Drugs Market Share by Application (2014-2019)
Figure China Antibody Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Antibody Drugs Market Share (2018-2019)
Table China Antibody Drugs Market Size by Type (2014-20189) (Million US$)
Table China Antibody Drugs Market Share by Type (2014-2019)
Table China Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table China Antibody Drugs Market Share by Application (2014-2019)
Figure Japan Antibody Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Antibody Drugs Market Share (2018-2019)
Table Japan Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Antibody Drugs Market Share by Type (2014-2019)
Table Japan Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Antibody Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Antibody Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Antibody Drugs Market Share (2018-2019)
Table Southeast Asia Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Antibody Drugs Market Share by Type (2014-2019)
Table Southeast Asia Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Antibody Drugs Market Share by Application (2014-2019)
Figure India Antibody Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Antibody Drugs Market Share (2018-2019)
Table India Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table India Antibody Drugs Market Share by Type (2014-2019)
Table India Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table India Antibody Drugs Market Share by Application (2014-2019)
Figure Central & South America Antibody Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Antibody Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Antibody Drugs Market Share (2018-2019)
Table Central & South America Antibody Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Antibody Drugs Market Share by Type (2014-2019)
Table Central & South America Antibody Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Antibody Drugs Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Antibody Drugs Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table Novartis Recent Development
Table Amgen Company Details
Table Amgen Revenue in Antibody Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table Amgen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Antibody Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Antibody Drugs Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Antibody Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Antibody Drugs Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Antibody Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Antibody Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Antibody Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Antibody Drugs Market Size Share by Regions (2019-2025)
Figure Global Antibody Drugs Market Size Share by Regions in 2025
Figure United States Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Antibody Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Antibody Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Antibody Drugs Market Size by Product (2019-2025)
Figure Global Antibody Drugs Market Size by Product in 2025
Table Global Antibody Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Antibody Drugs Market Size by Application (2019-2025)
Figure Global Antibody Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

Our expert analysts collaborate directly with you to comprehend your specific needs.
Get data on regions, segments, competitors, and vendors of your choice.
Information is presented in alignment with your exact preferences and formatting.

Request for customization

Ask For Discount

Free Sample Report

"Find new revenue generation opportunities"

Antibody Drugs Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032